ES2195002T3 - Antagonistas de los receptores de la endotelina. - Google Patents

Antagonistas de los receptores de la endotelina.

Info

Publication number
ES2195002T3
ES2195002T3 ES96926841T ES96926841T ES2195002T3 ES 2195002 T3 ES2195002 T3 ES 2195002T3 ES 96926841 T ES96926841 T ES 96926841T ES 96926841 T ES96926841 T ES 96926841T ES 2195002 T3 ES2195002 T3 ES 2195002T3
Authority
ES
Spain
Prior art keywords
antagonists
endotheline
receptors
endotheline receptors
tiazols
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96926841T
Other languages
English (en)
Inventor
John Duncan Elliott
Juan Ignacio Luengo
Jia-Ning Xiang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Corp
Original Assignee
SmithKline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp
Application granted granted Critical
Publication of ES2195002T3 publication Critical patent/ES2195002T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

SE DESCRIBEN NUEVOS ISOXAZOLES, OXAZOLES, TIAZOLES, ISOTIAZOLES E IMIDAZOLES, COMPOSICIONES FARMACEUTICAS QUE CONTIENEN ESTOS COMPUESTOS Y SU USO COMO ANTAGONISTAS DEL RECEPTOR DE LA ENDOTELINA.
ES96926841T 1995-08-02 1996-08-02 Antagonistas de los receptores de la endotelina. Expired - Lifetime ES2195002T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US179495P 1995-08-02 1995-08-02
US1100996P 1996-02-01 1996-02-01

Publications (1)

Publication Number Publication Date
ES2195002T3 true ES2195002T3 (es) 2003-12-01

Family

ID=26669476

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96926841T Expired - Lifetime ES2195002T3 (es) 1995-08-02 1996-08-02 Antagonistas de los receptores de la endotelina.

Country Status (5)

Country Link
EP (1) EP0841926B1 (es)
JP (1) JPH11513022A (es)
DE (1) DE69626986T2 (es)
ES (1) ES2195002T3 (es)
WO (1) WO1997004774A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000504013A (ja) * 1996-02-01 2000-04-04 スミスクライン・ビーチャム・コーポレイション エンドセリンレセプターアンタゴニスト
JP2002532729A (ja) 1998-12-23 2002-10-02 グラクソ グループ リミテッド 核内受容体のリガンドのアッセイ
EP1454625A1 (en) * 2003-03-06 2004-09-08 Speedel Development AG Pyridylsulfonamidyl-pyrimidines for the treatment of diabetic nephropathies
WO2006023865A1 (en) 2004-08-23 2006-03-02 Wyeth Oxazolo-naphthyl acids as plaminogen activator inhibtor type-1 (pai-1) modulators useful in the treatment of thrombosis and cardiovascular diseases
AU2005277137A1 (en) 2004-08-23 2006-03-02 Wyeth Pyrrolo-naphthyl acids as PAI-1 inhibitors
CN101044127A (zh) 2004-08-23 2007-09-26 惠氏公司 用作纤溶酶原激活剂抑制剂－1的噻唑基－萘基酸
KR20090020559A (ko) * 2006-05-29 2009-02-26 니콕스 에스. 에이. 엔도셀린 수용체 길항제로서의 질화 헤테로시클릭 화합물
CN104146998A (zh) * 2014-08-05 2014-11-19 广东食品药品职业学院 5-羟基-7-甲氧基色原酮在制药中的新应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700661A (en) * 1968-11-22 1972-10-24 Hoffmann La Roche Total steroid synthesis employing substituted isoxazole derivatives
CH641464A5 (de) * 1979-11-22 1984-02-29 Lonza Ag Verfahren zur herstellung von 4-amino-6-hydroxy-3-phenyl-isoxazolo(5,4-b)pyridin-5-carbonitrilen.
EP0403158A3 (en) * 1989-06-14 1991-12-18 Smithkline Beecham Corporation Imidazolyl-alkenoic acids
WO1994002474A1 (en) * 1992-07-17 1994-02-03 Smithkline Beecham Corporation Endothelin receptor antagonists
WO1994027597A1 (en) * 1993-05-21 1994-12-08 Smithkline Beecham Corporation Imidazolyl-alkenoic acid angiotensin ii receptor antagonists
US5541213A (en) * 1993-06-24 1996-07-30 Eisai Co., Ltd. Propenoic acid derivatives diazole propenoic acid compounds which have useful pharmaceutical utility
DE69526738T2 (de) * 1994-09-02 2003-02-06 Smithkline Beecham Corp., Philadelphia Endothelin-rezeptor-antagonisten

Also Published As

Publication number Publication date
WO1997004774A1 (en) 1997-02-13
DE69626986D1 (de) 2003-04-30
EP0841926A1 (en) 1998-05-20
DE69626986T2 (de) 2004-02-05
JPH11513022A (ja) 1999-11-09
EP0841926A4 (en) 1999-08-04
EP0841926B1 (en) 2003-03-26

Similar Documents

Publication Publication Date Title
UY26808A1 (es) Compuestos de succinimida heterocíclicos fusionados y análogos de los mismos, modulares de la función del receptor de hormona nuclear
BR9206237A (pt) Uso de derivados de tetrahidrocarbazole como receptores agonistas 5-HT1.
ES2164054T3 (es) Antagonistas de receptores de endotelina.
ES2172535T3 (es) Antagonistas de los receptores de la endotelina.
AR017296A1 (es) Uso de un antagonista del receptor de 5-hidroxitriptamina y compuestos antagonistas
MX9400071A (es) Antagonistas del receptor de endotelina.
CR6478A (es) Moduladores del receptor glucocorticoide
ES2091877T3 (es) Uso de antagonistas de la angiotensina ii para la fabricacion de un medicamento para el tratamiento de la hiperuricemia.
MX9207074A (es) Piperazinil- y piperidinil -ciclohexanoles y composicion farmaceutica que los comprende
EA200101177A1 (ru) Производные индола в качестве антагонистов прогестерона
UY26482A1 (es) Bifenil sulfonamidas como antagonistas de receptores de angiotensina endotelina duales
ECSP077236A (es) Moduladores del receptor de progesterona que comprenden los derivados del pirrol-oxindol y los usos de los mismos
EA199900045A1 (ru) Производные спиропиперидина и их использование в качестве терапевтических агентов
ES2153907T3 (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y su uso como antagonistas del receptor 5ht1d.
ES2184797T3 (es) Uso de antagonistas de serotonina (5ht3) para el tratamiento de la fibromialgia.
AR002268A1 (es) Antagonistas de vasopresina de benzacepina triciclicos, un procedimiento para su preparacion, una composicion farmaceutica que los contiene y el uso dedichos compuestos para preparar composiciones farmaceuticas.
MX9705296A (es) Compuestos novedosos de imidazol 1,4,5-susbtituidos y el uso de los mismos para preparar composiciones para uso en terapia.
MX9204786A (es) Antagonistas del receptor 5-ht4 y composicion farmaceutica que los contiene.
TR200002896T2 (tr) Kalsilitik Bileşimler
ES2190487T3 (es) Nuevos agonistas y antagonistas del receptor de adenosina a1.
NO994850L (no) Farmakologiske midler
ES2171196T3 (es) Uso de antagonistas del receptor cck-b para el tratamiento de trastornos del sueño.
ES2195002T3 (es) Antagonistas de los receptores de la endotelina.
ES2076595T3 (es) Derivados de amidinofenilalanina, procedimiento para su preparacion, su empleo y agentes que los contienen.
SV2002000005A (es) Heterociclos 2-arilimino substituidos y composiciones que los contienen para usar como agentes que ligan el receptor de la progesterona ref. 5048p1-sv